Welcome to the new and improved FierceBiotech

laptop and mobile phone

We are pleased to introduce you to the redesigned FierceBiotech, which brings all of your Biotech news to a central hub through a more reader-friendly experience.   

Now you can find all of our Biotech related content including stories from our sister sites, FierceBiotechResearch, FierceBiotechIT and FierceCRO on one site: www.fiercebiotech.com. You will still receive your regular newsletters, so if you subscribe to one of our sister publications the only change you’ll see is a more slimmed-down format.

What’s more exciting than what you’ll see at kickoff are the new features that will enhance our reporting – from social integrations to data visualizations – in the days and weeks to come.   

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

You’ll also be able to enjoy our content more fully when you're on the go, because our sites will be viewable on desktop, mobile and tablet devices. 

We’re excited to debut the new capabilities the redesign allows and we hope you enjoy our new look. Take a spin through the sites and let me know what you think. 

As always, thank you for reading and for being a part of the FierceBiotech community.  – Rebecca Willumson (email | Twitter)

Suggested Articles

Antonio Gualberto, M.D., Ph.D., helped found Kura Oncology and ran its R&D as CMO. Now, he’s moving over to fill the same role at H3 Biomedicine.

California clinical trial artificial intelligence startup Saama Technologies has teamed up with Big Pharma Pfizer.

One day after its Opdivo-paired prospect flopped, Five Prime is farming out some preclinical antibodies to keep its clinical-stage pipeline alive.